Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director's Dealing

27 Mar 2007 14:54

Chamberlin & Hill PLC27 March 2007 CHAMBERLIN & HILL PLC 27 March 2007 Directors Dealing This notification is made in accordance with section 329 of the Companies Act1985 and Rule 17 of the AIM Rules. On 27 March 2007, the following awards over ordinary shares in the Company weremade under the rules of the Chamberlin & Hill Performance Share Plan and theChamberlin & Hill Share Option Plan to Directors of the Company, as follows: Chamberlin & Hill Performance Share Plan ("PSP") Director Number of Shares held under Award Tim Hair 49,995 Mark Bache 38,457 Adam Vicary 33,843 Under the PSP, awards are structured as nil-cost options granted under theEnterprise Management Incentives Scheme ("EMI Option") contained in Schedule 5to the Income Tax (Earnings and Pensions) Act 2003. No consideration was paid for the grant of the EMI Options. The vesting of an EMI Option is subject to the continued employment of theparticipant and the satisfaction of a performance condition set by theRemuneration Committee of the Company (see below). The EMI Options willnormally become exercisable in three equal tranches on each of the third, fourthand fifth anniversaries of the date of grant subject to the satisfaction of aperformance condition set by the Remuneration Committee of the Company. To theextent that an EMI Option or any part of an EMI Option becomes exercisable, itremains exercisable until the tenth anniversary of the date of grant. The proportion of awards that become exercisable under each tranche of the EMIOption varies on a straight line basis, from 25% to 100%, for average growth inunderlying fully diluted EPS of between 5% p.a. and 10% p.a. above RPI over theperiod between the grant and exercise dates. No options are exercisable ifgrowth is below this range. The base line for the purposes of this calculationis underlying fully diluted EPS, before exceptional and operating one-off costs,for the year ended 31 March 2007. Chamberlin & Hill Share Option Plan ("SOP") Director Number of Shares held under Option Tim Hair 202,282 Mark Bache 103,734 No consideration was paid for the grant of options under the SOP, which arestructured as market value options. The options will normally become exercisable in three equal tranches on each ofthe third, fourth and fifth anniversaries of the date of grant subject to thesatisfaction of performance conditions set by the Remuneration Committee of theCompany (see below). To the extent that an option or any part of an optionbecomes exercisable, it remains exercisable until the tenth anniversary of thedate of grant. The proportion of awards that become exercisable under each tranche of the SOPvaries on a straight line basis, from 25% to 100%, for average growth in TotalShareholder Return of between 15% p.a. and 25% p.a. over the period betweengrant and exercise dates, subject to achieving a minimum average growth inunderlying fully diluted EPS of 5% p.a. above RPI. No options are exercisable ifgrowth is below this range. The option price payable by each participant on the exercise of his option is192.8 pence. The rules of both the EMI Option and the SOP require that total awards, underthese and any other employee share option plan adopted by the company, must notexceed 10% of the Company's ordinary share capital over a 10 year period. Anyaward in excess of this limit would be subject to market purchase. Chamberlin & Hill Executive Share Option Scheme 1997 On 27 March 2007, Tim Hair surrendered for no consideration an option under theChamberlin & Hill Executive Share Option Scheme 1997 over 13,900 ordinary sharesin the Company. The option was granted on 21 June 2006 and had an exerciseprice per share of 215.5 pence. For further information, contact details are:Chamberlin & Hill plcTom Brown, Chairman 01922 707 100 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Jun 20247:00 amRNSCancellation - Chamberlin PLC
20th Jun 20246:00 pmRNSChamberlin
20th May 20245:02 pmRNSAppointment of Administrators & Nomad Resignation
10th May 202412:37 pmRNSUpdate
7th May 202412:36 pmRNSSuspension of Trading
7th May 202411:45 amRNSSuspension - Chamberlin plc
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.